Abstract
Several comorbidities are often associated to patients with essential hypertension. The coexistence of different risk factors and diseases such as diabetes mellitus (DM), chronic kidney disease (CKD) and coronary artery disease (CAD) can increase the incidence of brain damage. Moreover, obstructive sleep apnoea syndrome (OSAS) is also associated with an increased risk of stroke and other cardiovascular diseases. This chapter will address the associations between these diseases and conditions and hypertension and the mechanisms involved in the acceleration of the stroke-related and cognitive decline burden induced by high blood pressure values in these patients.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Seshadri S, Beiser A, Kelly-Hayes M, Kase CS, Au R, Kannel WB, Wolf PA (2006) The lifetime risk of stroke: estimates from the Framingham Study. Stroke 37(2):345–350
Weiner DE, Tighiouart H, Amin MG, Stark PC, MacLeod B, Griffith JL, Salem DN, Levey AS, Sarnak MJ (2004) Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol 15(5):1307–1315
Redline S, Yenokyan G, Gottlieb DJ, Shahar E, O’Connor GT, Resnick HE, Diener-West M, Sanders MH, Wolf PA, Geraghty EM, Ali T, Lebowitz M, Punjabi NM (2010) Obstructive sleep apnea-hypopnea and incident stroke: the Sleep Heart Health Study. Am J Respir Crit Care Med 182(2):269–277
Cukierman-Yaffe T, Gerstein HC, Williamson JD, Lazar RM, Lovato L, Miller ME, Coker LH, Murray A, Sullivan MD, Marcovina SM, Launer LJ (2009) Relationship between baseline glycemic control and cognitive function in individuals with type 2 diabetes and other cardiovascular risk factors: the action to control cardiovascular risk in diabetes-memory in diabetes (ACCORDMIND) trial. Diabetes Care 32:221–226 [PMID: 19171735 doi:10.2337/dc08-1153]
Umegaki H, Kawamura T, Mogi N, Umemura T, Kanai A, Sano T (2008) Glucose control levels, ischaemic brain lesions, and hyperinsulinaemia were associated with cognitive dysfunction in diabetic elderly. Age Ageing 37:458–461 [PMID: 18339615 doi:10.1093/ageing/afn051]
Whitmer RA, Karter AJ, Yaffe K, Quesenberry CP, Selby JV (2009) Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA 301:1565–1572 [PMID:19366776 doi:10.1001/jama.2009.460]
Rizzo MR, Marfella R, Barbieri M, Boccardi V, Vestini F, Lettieri B, Canonico S, Paolisso G (2010) Relationships between daily acute glucose fluctuations and cognitive performance among aged type 2 diabetic patients. Diabetes Care 33:2169–2174 [PMID: 20573753 doi:10.2337/dc10-0389]
Jacobson AM, Musen G, Ryan CM, Silvers N, Cleary P, Waberski B, Burwood A, Weinger K, Bayless M, Dahms W, Harth J (2007) Long term effect of diabetes and its treatment on cognitive function. N Engl J Med 356:1842–1852
Neumann KF, Rojo L, Navarrete LP, FarÃas G, Reyes P, Maccioni RB (2008) Insulin resistance and Alzheimer’s disease: molecular links & clinical implications. Curr Alzheimer Res 5:438–447
Unger JW, Livingston JN, Moss AM (1991) Insulin receptors in the central nervous system: localization, signalling mechanisms and functional aspects. Prog Neurobiol 36:343–362
Di Carlo M, Pasquale Picone P, Carrotta R, Giacomazza D, Biagio S (2011) Alzheimer’s disease and type 2 diabetes: different pathologies and same features. In: Zimering M (ed) Topics in the prevention, treatment and complications of type 2 diabetes. INTECH Open Access Publisher, Croatia
Ding J, Strachan MW, Reynolds RM, Frier BM, Deary IJ, Fowkes FG, Lee AJ, McKnight J, Halpin P, Swa K, Price JF (2010) Diabetic retinopathy and cognitive decline in older people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetes 59:2883–2889
Ness J, Aronow WS (1999) Prevalence of coexistence of coronary artery disease, ischemic stroke, and peripheral arterial disease in older persons, mean age 80 years, in an academic hospital-based geriatrics practice. J Am Geriatr Soc 47(10):1255–1256
Rokey R, Rolak LA, Harati Y, Kutka N, Verani MS (1984) Coronary artery disease in patients with cerebrovascular disease: a prospective study. Ann Neurol 16:50–53, CrossRefMedline
Di Pasquale G, Andreoli A, Pinelli G, Grazi P, Manini G, Tognetti F, Testa C (1986) Cerebral ischemia and asymptomatic coronary artery disease: a prospective study of 83 patients. Stroke 17:1098–1101
Jensen JK, Medina HM, Nørgaard BL, Øvrehus KA, Jensen JM, Nielsen LH, Maurovich-Horvat P, Engel LC, Januzzi JL, Hoffmann U, Truong QA (2012) Association of ischemic stroke to coronary artery disease using computed tomography coronary angiography. Int J Cardiol 160(3):171–174
Yoo J, Yang JH, Choi BW, Kim YD, Nam HS, Choi HY, Cho HJ, Lee HS, Cha MJ, Choi D, Nam CM, Jang Y, Lee DH, Kim J, Heo JH (2012) The frequency and risk of preclinical coronary artery disease detected using multichannel cardiac computed tomography in patients with ischemic stroke. Cerebrovasc Dis 33(3):286–294
Newman A, Fitzpatrick A, Lopez O et al (2005) Dementia and Alzheimer’s disease incidence in relationship to cardiovascular disease in the Cardiovascular Health Study cohort. J Am Geriatr Soc 53(7):1101–1107
Graban A, Bednarska-Makaruk M, Bochynska A, Lipczynska-Lojkowska W, Ryglewicz D, Wehr H (2009) Vascular and biochemical risk factors of vascular dementia after lacunar strokes (S-VaD) and after multiinfarcts in strategic areas (M-VaD). J Neurol Sci 283(1–2):116–118
Koschack J, Irle E (2005) Small hippocampal size in cognitively normal subjects with coronary artery disease. Neurobiol Aging 26:865–871
Soneira CF, Scott TM (1996) Severe cardiovascular disease and Alzheimer’s disease: senile plaque formation in cortical areas. Clin Anat 9:118–127
Stellos K, Katsiki N, Tatsidou P, Bigalke B, Laske C (2012) Association of platelet activation with vascular cognitive impairment: implications in dementia development? Curr Vasc Pharmacol 12(1):152–154
Gardner TJ, Horneffer PJ, Manolio TA, Pearson TA, Gott VL, Baumgartner WA, Borkon AM, Watkins L Jr, Reitz BA (1985) Stroke following coronary artery bypass grafting: a ten-year study. Ann Thorac Surg 40(6):574–581
Puskas JD, Winston AD, Wright CE, Gott JP, Brown WM 3rd, Craver JM, Jones EL, Guyton RA, Weintraub WS (2000) Stroke after coronary artery operation: incidence, correlates, outcome, and cost. Ann Thorac Surg 69(4):1053–1056
Krahn AD, Manfreda J, Tate RB, Mathewson FA, Cuddy TE (1995) The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Med 98(5):476–484
European Heart Rhythm Association; European Association for Cardio-Thoracic Surgery, Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, Van Gelder IC, Al-Attar N, Hindricks G, Prendergast B, Heidbuchel H, Alfieri O, Angelini A, Atar D, Colonna P, De Caterina R, De Sutter J, Goette A, Gorenek B, Heldal M, Hohloser SH, Kolh P, Le Heuzey JY, Ponikowski P, Rutten FH (2010) Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 31(19):2369–2429
Lin HJ, Wolf PA, Kelly-Hayes M, Beiser AS, Kase CS, Benjamin EJ, D’Agostino RB (1996) Stroke severity in atrial fibrillation. The Framingham Study. Stroke 27(10):1760–1764
Ott A, Breteler MM, de Bruyne MC, van Harskamp F, Grobbee DE, Hofman A (1997) Atrial fibrillation and dementia in a population-based study. The Rotterdam Study. Stroke 28(2):316–321
Collins AJ, Foley RN, Herzog C et al (2011) US renal data system 2010 annual data report. Am J Kidney Dis 57(Suppl 1):A8, e1–e526
Seifter JL, Samuels MA (2011) Uremic encephalopathy and other brain disorders associated with renal failure. Semin Neurol 31(2):139–143
Zepeda-Orozco D, Quigley R (2012) Dialysis disequilibrium syndrome. Pediatr Nephrol 27(12):2205–2211
Alfrey AC, LeGendre GR, Kachney MD (1976) The dialysis encephalopathy syndrome: possible aluminum intoxication. N Engl J Med 294:184–188
Nakayama M, Metoki H, Terawaki H et al (2007) Kidney dysfunction as a risk factor for first symptomatic stroke events in a general Japanese population - the Ohasama study. Nephrol Dial Transplant 22:1910
Vazquez E, Sanchez-Perales C, Lozano C et al (2003) Comparison of prognostic value of atrial fibrillation versus sinus rhythm in patients on long-term hemodialysis. Am J Cardiol 92:868
Kimmel PL, Thamer M, Richard CM, Ray NF (1998) Psychiatric illness in patients with end-stage renal disease. Am J Med 105(3):214
Cohen SD, Norris L, Acquaviva K, Peterson RA, Kimmel PL (2007) Screening, diagnosis, and treatment of depression in patients with end-stage renal disease. Clin J Am Soc Nephrol 2(6):1332
Kim CD, Lee HJ, Kim DJ et al (2007) High prevalence of leukoaraiosis in cerebral magnetic resonance images of patients on peritoneal dialysis. Am J Kidney Dis 50:98
Martinez-Vea A, Salvadó E, Bardajà A et al (2006) Silent cerebral white matter lesions and their relationship with vascular risk factors in middle-aged predialysis patients with CKD. Am J Kidney Dis 47:241
Gerson AC, Butler R, Moxey-Mims M et al (2006) Neurocognitive outcomes in children with chronic kidney disease: Current findings and contemporary endeavors. Ment Retard Dev Disabil Res Rev 12(3):208–215
Kurella Tamura M, Wadley V, Yaffe K et al (2008) Kidney function and cognitive impairment in US adults: the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study. Am J Kidney Dis 52(2):227
Wolfgram DF, Szabo A, Murray AM, Whittle J (2015) Risk of dementia in peritoneal dialysis patients compared with hemodialysis patients. Perit Dial Int 35(2):189–198
Somers VK, White DP, Amin R et al (2008) Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing. J Am Coll Cardiol 52(8):686–717
Heusser K, Tank J, Engeli S et al (2010) Carotid baroreceptor stimulation, sympathetic activity, baroreflex function, and blood pressure in hypertensive patients. Hypertension 55(3):619–626
Narkiewicz K, van de Borne PJ, Pesek CA, Dyken ME, Montano N, Somers VK (1999) Selective potentiation of peripheral chemoreflex sensitivity in obstructive sleep apnea. Circulation 99(9):1183–1189
Weiss JW, Liu Y, Li X, Ji ES (2012) Nitric oxide and obstructive sleep apnea. Respir Physiol Neurobiol 184(2):192–196
Manolis AJ, Poulimenos LE, Kallistratos MS, Gavras I, Gavras H (2014) Sympathetic overactivity in hypertension and cardiovascular disease. Curr Vasc Pharmacol 12(1):4–15
Devulapally K, Pongonis R, Khayat R (2009) OSA: the new cardiovascular disease: part II: overview of cardiovascular diseases associated with obstructive sleep apnea. Heart Fail Rev 14(3):155–164
Gami AS, Pressman G, Caples SM et al (2004) Association of atrial fibrillation and obstructive sleep apnea. Circulation 110(4):364–367
Marin JM, Carrizo SJ, Vicente E, Agusti AG (2005) Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 365(9464):1046–1053
Gonzaga C, Bertolami A, Bertolami M, Amodeo C, Calhoun D (2015) Obstructive sleep apnea, hypertension and cardiovascular diseases. J Hum Hypertens 29(12):705–712
Logan AG, Perlikowski SM, Mente A et al (2001) High prevalence of unrecognized sleep apnoea in drug-resistant hypertension. J Hypertens 19(12):2271–2277
Gonçalves SC, Martinez D, Gus M et al (2007) Obstructive sleep apnea and resistant hypertension: a case-control study. Chest 132(6):1858–1862
Furtner M, Staudacher M, Frauscher B et al (2009) Cerebral vasoreactivity decreases overnight in severe obstructive sleep apnea syndrome: a study of cerebral hemodynamics. Sleep Med 10(8):875–881
Phillips SA, Olson EB, Morgan BJ, Lombard JH (2004) Chronic intermittent hypoxia impairs endothelium-dependent dilation in rat cerebral and skeletal muscle resistance arteries. Am J Physiol Heart Circ Physiol 286(1):H388–H393
Baguet JP, Hammer L, Lévy P et al (2005) The severity of oxygen desaturation is predictive of carotid wall thickening and plaque occurrence. Chest 128(5):3407–3412
Lipford MC, Flemming KD, Calvin AD et al (2015) Associations between cardioembolic stroke and obstructive sleep apnea. Sleep 38(11):1699–1705
Mehra R, Benjamin EJ, Shahar E et al (2006) Association of nocturnal arrhythmias with sleep-disordered breathing: the Sleep Heart Health Study. Am J Respir Crit Care Med 173(8):910–916
Yaranov DM, Smyrlis A, Usatii N et al (2015) Effect of obstructive sleep apnea on frequency of stroke in patients with atrial fibrillation. Am J Cardiol 115(4):461–465
Kim Y, Koo YS, Lee HY, Lee SY (2016) Can continuous positive airway pressure reduce the risk of stroke in obstructive sleep apnea patients? A systematic review and meta-analysis. PLoS One 11(1):e0146317
MartÃnez-GarcÃa MA, Soler-Cataluña JJ, Ejarque-MartÃnez L et al (2009) Continuous positive airway pressure treatment reduces mortality in patients with ischemic stroke and obstructive sleep apnea: a 5-year follow-up study. Am J Respir Crit Care Med 180(1):36–41
Yang Q, Wang Y, Feng J, Cao J, Chen B (2013) Intermittent hypoxia from obstructive sleep apnea may cause neuronal impairment and dysfunction in central nervous system: the potential roles played by microglia. Neuropsychiatr Dis Treat 9:1077–1086
Ferini-Strambi L, Baietto C, Di Gioia MR et al (2003) Cognitive dysfunction in patients with obstructive sleep apnea (OSA): partial reversibility after continuous positive airway pressure (CPAP). Brain Res Bull 61(1):87–92
Dewan NA, Nieto FJ, Somers VK (2015) Intermittent hypoxemia and OSA: implications for comorbidities. Chest 147(1):266–274
Kaminska M, Lafontaine AL, Kimoff RJ (2015) The interaction between obstructive sleep apnea and Parkinson’s disease: possible mechanisms and implications for cognitive function. Parkinsons Dis 2015:849472
Chen HL, Lu CH, Lin HC et al (2015) White matter damage and systemic inflammation in obstructive sleep apnea. Sleep 38(3):361–370
Daulatzai MA (2012) Pathogenesis of cognitive dysfunction in patients with obstructive sleep apnea: a hypothesis with emphasis on the nucleus tractus solitarius. Sleep Disord 2012:251096
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Manolis, A.J., Kallistratos, M.S., Vlahakos, D.V., Mitrakou, A., Poulimenos, L.E. (2016). Comorbidities Often Associated with Brain Damage in Hypertension: Diabetes, Coronary Artery Disease, Chronic Kidney Disease and Obstructive Sleep Apnoea. In: Coca, A. (eds) Hypertension and Brain Damage. Updates in Hypertension and Cardiovascular Protection. Springer, Cham. https://doi.org/10.1007/978-3-319-32074-8_4
Download citation
DOI: https://doi.org/10.1007/978-3-319-32074-8_4
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-32072-4
Online ISBN: 978-3-319-32074-8
eBook Packages: MedicineMedicine (R0)